quinazolines has been researched along with Diabetic Neuropathies in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (27.27) | 18.2507 |
| 2000's | 6 (54.55) | 29.6817 |
| 2010's | 2 (18.18) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dobrowsky, RT; Pan, P | 1 |
| Byrne, FM; Chapman, V; Cheetham, S; Vickers, S | 1 |
| Kamijo, M; Matsuoka, N; Minoura, K; Mutoh, S; Shimoshige, Y; Takakura, S | 1 |
| Kato, N; Oka, M | 1 |
| Bird, SJ; Brown, MJ; Foyt, HL; Spino, C; Watling, S | 1 |
| Arezzo, JC; Brown, MB; Greene, DA | 1 |
| Feldman, EL; Greene, DA; Stevens, MJ | 1 |
| Goto, T; Ikuma, K; Kawamura, I; Mutoh, S; Seki, J; Shimoshige, Y; Takakura, S; Yamamoto, T | 1 |
| Goto, T; Kawamura, I; Seki, J; Takakura, S; Yamamoto, T | 1 |
| Hasegawa, T; Kawamura, I; Kihara, M; Minoura, K; Mitsui, Y; Shioyama, M; Takahashi, M; Takakura, S | 1 |
| Ao, S; Fujiwara, T; Kikuchi, C; Nomura, K; Notsu, Y; Ohkubo, Y; Shingu, Y; Takano, Y; Yamaguchi, I | 1 |
2 review(s) available for quinazolines and Diabetic Neuropathies
| Article | Year |
|---|---|
Aldose reductase inhibitors.
Topics: Aldehyde Reductase; Binding Sites; Clinical Trials as Topic; Crystallography, X-Ray; Diabetic Neuropathies; Enzyme Inhibitors; Humans; Imidazoles; Imidazolidines; Naphthalenes; Quinazolines | 2001 |
Diabetic neuropathy: scope of the syndrome.
Topics: Aldehyde Reductase; Animals; Chronic Disease; Controlled Clinical Trials as Topic; Diabetic Foot; Diabetic Neuropathies; Disease Progression; Enzyme Inhibitors; Humans; Neural Conduction; Prevalence; Quinazolines; Syndrome | 1999 |
1 trial(s) available for quinazolines and Diabetic Neuropathies
| Article | Year |
|---|---|
Effect of aldose reductase inhibition on nerve conduction and morphometry in diabetic neuropathy. Zenarestat Study Group.
Topics: Action Potentials; Aldehyde Reductase; Biopsy; Diabetic Neuropathies; Double-Blind Method; Female; Humans; Male; Middle Aged; Neural Conduction; Quinazolines | 1999 |
8 other study(ies) available for quinazolines and Diabetic Neuropathies
| Article | Year |
|---|---|
Differential expression of neuregulin-1 isoforms and downregulation of erbin are associated with Erb B2 receptor activation in diabetic peripheral neuropathy.
Topics: Animals; Carrier Proteins; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Disease Progression; Down-Regulation; Erlotinib Hydrochloride; Intracellular Signaling Peptides and Proteins; MAP Kinase Signaling System; Mice; Neural Conduction; Neuregulin-1; Protein Isoforms; Protein Kinase Inhibitors; Quinazolines; Receptor, ErbB-2; Sural Nerve | 2013 |
Characterisation of pain responses in the high fat diet/streptozotocin model of diabetes and the analgesic effects of antidiabetic treatments.
Topics: Animal Feed; Animals; Behavior, Animal; Blood Glucose; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Diet, High-Fat; Glial Fibrillary Acidic Protein; Hypoglycemic Agents; Insulin; Linagliptin; Male; Metformin; Microscopy, Fluorescence; Neuroglia; Neurons; Pain; Pain Management; Pain Measurement; Pioglitazone; PPAR gamma; Purines; Quinazolines; Rats; Rats, Sprague-Dawley; Thiazolidinediones | 2015 |
Thirteen-month inhibition of aldose reductase by zenarestat prevents morphological abnormalities in the dorsal root ganglia of streptozotocin-induced diabetic rats.
Topics: Aldehyde Reductase; Animals; Axons; Cell Death; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Disease Models, Animal; Enzyme Inhibitors; Ganglia, Spinal; Male; Nerve Degeneration; Polymers; Quinazolines; Rats; Rats, Sprague-Dawley; Sensory Receptor Cells; Sural Nerve; Treatment Outcome; Wallerian Degeneration | 2009 |
Value of repeated measures of nerve conduction and quantitative sensory testing in a diabetic neuropathy trial.
Topics: Adolescent; Adult; Aged; Aldehyde Reductase; Algorithms; Cold Temperature; Data Interpretation, Statistical; Diabetic Neuropathies; Electrophysiology; Enzyme Inhibitors; Female; Glycated Hemoglobin; Humans; Male; Middle Aged; Neural Conduction; Neurons, Afferent; Quinazolines; Reproducibility of Results; Sample Size; Thermosensing; Vibration | 2006 |
The effects of zenarestat, an aldose reductase inhibitor, on peripheral neuropathy in Zucker diabetic fatty rats.
Topics: Aldehyde Reductase; Animals; Blood Glucose; Body Weight; Diabetes Mellitus, Type 2; Diabetic Neuropathies; Disease Models, Animal; Enzyme Inhibitors; Male; Quinazolines; Rats; Rats, Zucker | 2000 |
The effects of zenarestat, an aldose reductase inhibitor, on minimal F-wave latency and nerve blood flow in streptozotocin-induced diabetic rats.
Topics: Aldehyde Reductase; Animals; Blood Flow Velocity; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Enzyme Inhibitors; Male; Neural Conduction; Quinazolines; Rats; Rats, Sprague-Dawley; Reaction Time; Sciatic Nerve; Streptozocin | 2001 |
Effect of zenarestat, an aldose reductase inhibitor, on endoneurial blood flow in experimental diabetic neuropathy of rat.
Topics: Aldehyde Reductase; Animals; Diabetic Neuropathies; Enzyme Inhibitors; Hydrogen; Male; Microelectrodes; Nitric Oxide; Nitroarginine; Peripheral Nerves; Quinazolines; Rats; Rats, Sprague-Dawley; Regional Blood Flow; Sciatic Nerve | 2001 |
Characterization of a novel aldose reductase inhibitor, FR74366, and its effects on diabetic cataract and neuropathy in the rat.
Topics: Aldehyde Reductase; Animals; Cataract; Diabetic Neuropathies; Diabetic Retinopathy; Female; Kinetics; Lens, Crystalline; Male; Motor Neurons; Neural Conduction; Quinazolines; Rats; Rats, Inbred Strains; Sciatic Nerve; Sorbitol | 1991 |